ORTHOCELL LIMITED - Announcements

6.38%

$1.25

Market Cap $302.4M

Technology Scientific & Technical Instruments

Orthocell Limited is an Australia-based regenerative medicine company. The Company is... Orthocell Limited is an Australia-based regenerative medicine company. The Company is focused on regenerating mobility for patients by developing products for the repair of a variety of bone and soft tissue injuries. Its portfolio of products includes Striate+, Remplir, and OrthoACI. Striate+ is a sterile, resorbable collagen membrane used for guided bone and tissue regeneration in dental applications. Remplir is a collagen scaffold used in peripheral nerve repair. OrthoACI or autologous chondrocyte implantation is used for the treatment of articular cartilage defects in the knee and ankle. OrthoACI uses the patient’s own healthy cartilage cells called chondrocytes to assist the regeneration of damaged cartilage. The Company is engaged in the development of its tendon cell therapy in the United States. Its autologous tendon therapy is an advanced injectable cellular therapy for the treatment of chronic tendon injuries.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Announcements

Filter Results

All Price Sensitive Only

OCC	First US Distributors Signed for Remplirs US$1.6B market	PRICE SENSITIVE	23/04/25	157.31KB	Share
OCC	Quarterly Activity Report & Appendix 4C	PRICE SENSITIVE	14/04/25	681.89KB	Share
OCC	Remplir Regulatory Application Submitted for Hong Kong		10/04/25	170.58KB	Share
OCC	Regulatory Approval for Striate in US$65M Brazilian Market	PRICE SENSITIVE	09/04/25	218.96KB	Share
OCC	Orthocell Webinar Details - Remplir US FDA 510(k) Clearance		04/04/25	185.57KB	Share
OCC	Investor Presentation - US FDA 510(k) Clearance for Remplir	PRICE SENSITIVE	04/04/25	1.61MB	Share
OCC	Remplir Cleared to Commence Sales in US$1.6B US Market	PRICE SENSITIVE	04/04/25	197.97KB	Share
OCC	Trading Halt	PRICE SENSITIVE	03/04/25	232.81KB	Share
OCC	Orthocell to Present at HealthInvest Summit		02/04/25	2.6MB	Share
OCC	Application for quotation of securities - OCC		27/03/25	17.58KB	Share
OCC	First Sales of Striate in Germany, Austria & Swiss Region	PRICE SENSITIVE	26/03/25	177.86KB	Share
OCC	Regulatory approval to commence Striate sales in Singapore	PRICE SENSITIVE	18/03/25	195.13KB	Share
OCC	Notification regarding unquoted securities - OCC		17/03/25	17.16KB	Share
OCC	S&P DJI Announces March 2025 Quarterly Rebalance	PRICE SENSITIVE	07/03/25	174.42KB	Share
OCC	Notification regarding unquoted securities - OCC		04/03/25	24.29KB	Share
OCC	Cleansing Notice		03/03/25	119.42KB	Share
OCC	Application for quotation of securities - OCC		03/03/25	17.88KB	Share
OCC	Application for quotation of securities - OCC		28/02/25	17.59KB	Share
OCC	Orthocell Webinar Presentation		26/02/25	2.17MB	Share
OCC	Orthocell Webinar		25/02/25	168.06KB	Share
OCC	Appendix 4D & Half-Year Financial Report	PRICE SENSITIVE	24/02/25	3.91MB	Share
OCC	Remplir FDA Application submitted for US$84M Thai Market		21/02/25	181.65KB	Share
OCC	Cleansing Notice		18/02/25	118.92KB	Share
OCC	Application for quotation of securities - OCC		18/02/25	22.47KB	Share
OCC	Remplir Regulatory Application Submitted for Canada		03/02/25	185.58KB	Share
OCC	Strong Sales Drives Acceleration of Remplir Global Expansion		22/01/25	370.72KB	Share
OCC	Orthocell Receives $3.18 million R&D Tax Refund	PRICE SENSITIVE	20/01/25	180.28KB	Share
OCC	Quarterly Activity Report & Appendix 4C	PRICE SENSITIVE	15/01/25	730.34KB	Share
OCC	Notification regarding unquoted securities - OCC		14/01/25	19.32KB	Share
OCC	Application for quotation of securities - OCC		14/01/25	17.8KB	Share
OCC	Application for quotation of securities - OCC		14/01/25	17.58KB	Share
OCC	Option Terms and Conditions		14/01/25	277.1KB	Share
OCC	Proposed issue of securities - OCC		14/01/25	16.07KB	Share
OCC	Third Consecutive Quarter of Record Revenue for Orthocell	PRICE SENSITIVE	08/01/25	234.21KB	Share
OCC	US FDA Application Submitted for Remplir as US Launch Nears	PRICE SENSITIVE	19/12/24	184.68KB	Share
OCC	Major Milestone with First Sales of Remplir in Singapore	PRICE SENSITIVE	12/12/24	210.57KB	Share
OCC	Application for quotation of securities - OCC		10/12/24	20.22KB	Share
OCC	Cleansing Notice		03/12/24	118.99KB	Share
OCC	Change of Director's Interest Notice-John Van Der Wielen		03/12/24	196.9KB	Share
OCC	Application for quotation of securities - OCC		03/12/24	17.35KB	Share
OCC	Notification regarding unquoted securities - OCC		03/12/24	23.03KB	Share
OCC	Change of Director's Interest Notice-Paul Anderson		02/12/24	197.85KB	Share
OCC	Notification regarding unquoted securities - OCC		02/12/24	26.26KB	Share
OCC	Outstanding Remplir Study Results Pave Way for FDA Clearance	PRICE SENSITIVE	02/12/24	246.68KB	Share
OCC	Results of Annual General Meeting		29/11/24	198.37KB	Share
OCC	Trading Halt	PRICE SENSITIVE	29/11/24	562.8KB	Share
OCC	AGM Addresses by Chair and Managing Director		29/11/24	3.45MB	Share
OCC	Distributor Signed, Remplir Sales in Singapore to Commence	PRICE SENSITIVE	27/11/24	216.83KB	Share
OCC	Key Executives Appointed to Drive Remplir US Sales	PRICE SENSITIVE	11/11/24	215.57KB	Share
OCC	Letter, Supp Notice of Meeting & Replacement Proxy Form		07/11/24	519.55KB	Share
OCC	Cleansing Notice		31/10/24	118.93KB	Share
OCC	Application for quotation of securities - OCC		31/10/24	17.3KB	Share
OCC	Orthocell completes $17m Placement	PRICE SENSITIVE	31/10/24	170.56KB	Share
OCC	Cleansing Notice		29/10/24	119.74KB	Share
OCC	Notification of cessation of securities - OCC		29/10/24	13.85KB	Share
OCC	Application for quotation of securities - OCC		29/10/24	20.08KB	Share
OCC	Annual Report to Shareholders		25/10/24	8.45MB	Share
OCC	Letter to Shareholders, Notice of AGM & Proxy Form		25/10/24	685.19KB	Share
OCC	Proposed issue of securities - OCC		25/10/24	15.54KB	Share
OCC	Proposed issue of securities - OCC		25/10/24	15.76KB	Share
OCC	$17m Placement to Drive Further Growth as US Approval Nears	PRICE SENSITIVE	25/10/24	208.47KB	Share
OCC	Trading Halt	PRICE SENSITIVE	24/10/24	233.72KB	Share
OCC	Quarterly Activity Report & Appendix 4C	PRICE SENSITIVE	17/10/24	582.89KB	Share
OCC	Change of Director's Interest Notice-Paul Anderson		15/10/24	197.34KB	Share
OCC	Cleansing Notice		15/10/24	119.54KB	Share
OCC	Notification of cessation of securities - OCC		15/10/24	13.89KB	Share
OCC	Application for quotation of securities - OCC		15/10/24	17.99KB	Share
OCC	Regulatory approval to commence Remplir sales in Singapore	PRICE SENSITIVE	08/10/24	232.64KB	Share
OCC	Trading Halt	PRICE SENSITIVE	07/10/24	234.55KB	Share
OCC	Pause in Trading	PRICE SENSITIVE	07/10/24	114.17KB	Share
OCC	Second Consecutive Record Quarter as Revenue Exceeds $2m	PRICE SENSITIVE	07/10/24	240.19KB	Share
OCC	Date of AGM & Closing Date for Director Nominations		04/10/24	111.14KB	Share
OCC	Notification of cessation of securities - OCC		17/09/24	13.94KB	Share
OCC	Further regarding Company Presentation		11/09/24	117.94KB	Share
OCC	First sales of Striate in major new market of Canada	PRICE SENSITIVE	06/09/24	231.77KB	Share
OCC	Appendix 4G		30/08/24	270.15KB	Share
OCC	Corporate Governance Statement		30/08/24	319.76KB	Share
OCC	Appendix 4E & Annual Report	PRICE SENSITIVE	30/08/24	8.54MB	Share
OCC	Company Presentation	PRICE SENSITIVE	30/08/24	3.1MB	Share
OCC	Notification regarding unquoted securities - OCC		08/08/24	18.09KB	Share
OCC	Application for quotation of securities - OCC		08/08/24	17.82KB	Share
OCC	Striate Expansion Continues with Singapore Application		29/07/24	218.9KB	Share
OCC	Global Market Expansion Accelerates - New Regions Pending		24/07/24	568.54KB	Share
OCC	Quarterly Activity Report & Appendix 4C	PRICE SENSITIVE	16/07/24	501.91KB	Share
OCC	Regulatory Approval to Commence Sales for Striate in Canada	PRICE SENSITIVE	11/07/24	220.67KB	Share
OCC	Trading Halt	PRICE SENSITIVE	10/07/24	563.84KB	Share
OCC	Pause in Trading	PRICE SENSITIVE	10/07/24	112.67KB	Share
OCC	Record Quarterly and Yearly Revenue Show Outstanding Growth	PRICE SENSITIVE	09/07/24	247.7KB	Share
OCC	Notification regarding unquoted securities - OCC		12/06/24	21.28KB	Share
OCC	Proposed issue of securities - OCC		11/06/24	19.38KB	Share
OCC	Third Revenue Generating Product to be Launched in SmrtGraft	PRICE SENSITIVE	11/06/24	277.81KB	Share
OCC	Notification of cessation of securities - OCC		05/06/24	14.41KB	Share
OCC	Outstanding 98.6% Success Rate in Striate Implant Study	PRICE SENSITIVE	14/05/24	261.74KB	Share
OCC	Compelling 85% Success Rate Remplir Study now published		30/04/24	241.94KB	Share
OCC	Change of Director's Interest Notice-John Van Der Wielen		24/04/24	195.72KB	Share
OCC	Securities Trading Policy		24/04/24	266.3KB	Share
OCC	Change of Director's Interest Notice-John Van Der Wielen		16/04/24	195.7KB	Share
OCC	Orthocell receives $3.05m R&D tax incentive refund	PRICE SENSITIVE	15/04/24	198.23KB	Share
OCC	Quarterly Activity Report & Appendix 4C	PRICE SENSITIVE	08/04/24	591.72KB	Share
OCC	Part 1 Remplir US Market Authorisation Successfully Complete	PRICE SENSITIVE	25/03/24	255.02KB	Share

OCC First US Distributors Signed for Remplirs US$1.6B market
23/04/25	PRICE SENSITIVE	157.31KB	Share
OCC Quarterly Activity Report & Appendix 4C
14/04/25	PRICE SENSITIVE	681.89KB	Share
OCC Remplir Regulatory Application Submitted for Hong Kong
10/04/25		170.58KB	Share
OCC Regulatory Approval for Striate in US$65M Brazilian Market
09/04/25	PRICE SENSITIVE	218.96KB	Share
OCC Orthocell Webinar Details - Remplir US FDA 510(k) Clearance
04/04/25		185.57KB	Share
OCC Investor Presentation - US FDA 510(k) Clearance for Remplir
04/04/25	PRICE SENSITIVE	1.61MB	Share
OCC Remplir Cleared to Commence Sales in US$1.6B US Market
04/04/25	PRICE SENSITIVE	197.97KB	Share
OCC Trading Halt
03/04/25	PRICE SENSITIVE	232.81KB	Share
OCC Orthocell to Present at HealthInvest Summit
02/04/25		2.6MB	Share
OCC Application for quotation of securities - OCC
27/03/25		17.58KB	Share
OCC First Sales of Striate in Germany, Austria & Swiss Region
26/03/25	PRICE SENSITIVE	177.86KB	Share
OCC Regulatory approval to commence Striate sales in Singapore
18/03/25	PRICE SENSITIVE	195.13KB	Share
OCC Notification regarding unquoted securities - OCC
17/03/25		17.16KB	Share
OCC S&P DJI Announces March 2025 Quarterly Rebalance
07/03/25	PRICE SENSITIVE	174.42KB	Share
OCC Notification regarding unquoted securities - OCC
04/03/25		24.29KB	Share
OCC Cleansing Notice
03/03/25		119.42KB	Share
OCC Application for quotation of securities - OCC
03/03/25		17.88KB	Share
OCC Application for quotation of securities - OCC
28/02/25		17.59KB	Share
OCC Orthocell Webinar Presentation
26/02/25		2.17MB	Share
OCC Orthocell Webinar
25/02/25		168.06KB	Share
OCC Appendix 4D & Half-Year Financial Report
24/02/25	PRICE SENSITIVE	3.91MB	Share
OCC Remplir FDA Application submitted for US$84M Thai Market
21/02/25		181.65KB	Share
OCC Cleansing Notice
18/02/25		118.92KB	Share
OCC Application for quotation of securities - OCC
18/02/25		22.47KB	Share
OCC Remplir Regulatory Application Submitted for Canada
03/02/25		185.58KB	Share
OCC Strong Sales Drives Acceleration of Remplir Global Expansion
22/01/25		370.72KB	Share
OCC Orthocell Receives $3.18 million R&D Tax Refund
20/01/25	PRICE SENSITIVE	180.28KB	Share
OCC Quarterly Activity Report & Appendix 4C
15/01/25	PRICE SENSITIVE	730.34KB	Share
OCC Notification regarding unquoted securities - OCC
14/01/25		19.32KB	Share
OCC Application for quotation of securities - OCC
14/01/25		17.8KB	Share
OCC Application for quotation of securities - OCC
14/01/25		17.58KB	Share
OCC Option Terms and Conditions
14/01/25		277.1KB	Share
OCC Proposed issue of securities - OCC
14/01/25		16.07KB	Share
OCC Third Consecutive Quarter of Record Revenue for Orthocell
08/01/25	PRICE SENSITIVE	234.21KB	Share
OCC US FDA Application Submitted for Remplir as US Launch Nears
19/12/24	PRICE SENSITIVE	184.68KB	Share
OCC Major Milestone with First Sales of Remplir in Singapore
12/12/24	PRICE SENSITIVE	210.57KB	Share
OCC Application for quotation of securities - OCC
10/12/24		20.22KB	Share
OCC Cleansing Notice
03/12/24		118.99KB	Share
OCC Change of Director's Interest Notice-John Van Der Wielen
03/12/24		196.9KB	Share
OCC Application for quotation of securities - OCC
03/12/24		17.35KB	Share
OCC Notification regarding unquoted securities - OCC
03/12/24		23.03KB	Share
OCC Change of Director's Interest Notice-Paul Anderson
02/12/24		197.85KB	Share
OCC Notification regarding unquoted securities - OCC
02/12/24		26.26KB	Share
OCC Outstanding Remplir Study Results Pave Way for FDA Clearance
02/12/24	PRICE SENSITIVE	246.68KB	Share
OCC Results of Annual General Meeting
29/11/24		198.37KB	Share
OCC Trading Halt
29/11/24	PRICE SENSITIVE	562.8KB	Share
OCC AGM Addresses by Chair and Managing Director
29/11/24		3.45MB	Share
OCC Distributor Signed, Remplir Sales in Singapore to Commence
27/11/24	PRICE SENSITIVE	216.83KB	Share
OCC Key Executives Appointed to Drive Remplir US Sales
11/11/24	PRICE SENSITIVE	215.57KB	Share
OCC Letter, Supp Notice of Meeting & Replacement Proxy Form
07/11/24		519.55KB	Share
OCC Cleansing Notice
31/10/24		118.93KB	Share
OCC Application for quotation of securities - OCC
31/10/24		17.3KB	Share
OCC Orthocell completes $17m Placement
31/10/24	PRICE SENSITIVE	170.56KB	Share
OCC Cleansing Notice
29/10/24		119.74KB	Share
OCC Notification of cessation of securities - OCC
29/10/24		13.85KB	Share
OCC Application for quotation of securities - OCC
29/10/24		20.08KB	Share
OCC Annual Report to Shareholders
25/10/24		8.45MB	Share
OCC Letter to Shareholders, Notice of AGM & Proxy Form
25/10/24		685.19KB	Share
OCC Proposed issue of securities - OCC
25/10/24		15.54KB	Share
OCC Proposed issue of securities - OCC
25/10/24		15.76KB	Share
OCC $17m Placement to Drive Further Growth as US Approval Nears
25/10/24	PRICE SENSITIVE	208.47KB	Share
OCC Trading Halt
24/10/24	PRICE SENSITIVE	233.72KB	Share
OCC Quarterly Activity Report & Appendix 4C
17/10/24	PRICE SENSITIVE	582.89KB	Share
OCC Change of Director's Interest Notice-Paul Anderson
15/10/24		197.34KB	Share
OCC Cleansing Notice
15/10/24		119.54KB	Share
OCC Notification of cessation of securities - OCC
15/10/24		13.89KB	Share
OCC Application for quotation of securities - OCC
15/10/24		17.99KB	Share
OCC Regulatory approval to commence Remplir sales in Singapore
08/10/24	PRICE SENSITIVE	232.64KB	Share
OCC Trading Halt
07/10/24	PRICE SENSITIVE	234.55KB	Share
OCC Pause in Trading
07/10/24	PRICE SENSITIVE	114.17KB	Share
OCC Second Consecutive Record Quarter as Revenue Exceeds $2m
07/10/24	PRICE SENSITIVE	240.19KB	Share
OCC Date of AGM & Closing Date for Director Nominations
04/10/24		111.14KB	Share
OCC Notification of cessation of securities - OCC
17/09/24		13.94KB	Share
OCC Further regarding Company Presentation
11/09/24		117.94KB	Share
OCC First sales of Striate in major new market of Canada
06/09/24	PRICE SENSITIVE	231.77KB	Share
OCC Appendix 4G
30/08/24		270.15KB	Share
OCC Corporate Governance Statement
30/08/24		319.76KB	Share
OCC Appendix 4E & Annual Report
30/08/24	PRICE SENSITIVE	8.54MB	Share
OCC Company Presentation
30/08/24	PRICE SENSITIVE	3.1MB	Share
OCC Notification regarding unquoted securities - OCC
08/08/24		18.09KB	Share
OCC Application for quotation of securities - OCC
08/08/24		17.82KB	Share
OCC Striate Expansion Continues with Singapore Application
29/07/24		218.9KB	Share
OCC Global Market Expansion Accelerates - New Regions Pending
24/07/24		568.54KB	Share
OCC Quarterly Activity Report & Appendix 4C
16/07/24	PRICE SENSITIVE	501.91KB	Share
OCC Regulatory Approval to Commence Sales for Striate in Canada
11/07/24	PRICE SENSITIVE	220.67KB	Share
OCC Trading Halt
10/07/24	PRICE SENSITIVE	563.84KB	Share
OCC Pause in Trading
10/07/24	PRICE SENSITIVE	112.67KB	Share
OCC Record Quarterly and Yearly Revenue Show Outstanding Growth
09/07/24	PRICE SENSITIVE	247.7KB	Share
OCC Notification regarding unquoted securities - OCC
12/06/24		21.28KB	Share
OCC Proposed issue of securities - OCC
11/06/24		19.38KB	Share
OCC Third Revenue Generating Product to be Launched in SmrtGraft
11/06/24	PRICE SENSITIVE	277.81KB	Share
OCC Notification of cessation of securities - OCC
05/06/24		14.41KB	Share
OCC Outstanding 98.6% Success Rate in Striate Implant Study
14/05/24	PRICE SENSITIVE	261.74KB	Share
OCC Compelling 85% Success Rate Remplir Study now published
30/04/24		241.94KB	Share
OCC Change of Director's Interest Notice-John Van Der Wielen
24/04/24		195.72KB	Share
OCC Securities Trading Policy
24/04/24		266.3KB	Share
OCC Change of Director's Interest Notice-John Van Der Wielen
16/04/24		195.7KB	Share
OCC Orthocell receives $3.05m R&D tax incentive refund
15/04/24	PRICE SENSITIVE	198.23KB	Share
OCC Quarterly Activity Report & Appendix 4C
08/04/24	PRICE SENSITIVE	591.72KB	Share
OCC Part 1 Remplir US Market Authorisation Successfully Complete
25/03/24	PRICE SENSITIVE	255.02KB	Share

REFRESH

1 2 3 4 5 6

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last $1.25		Change 0.075(6.38%)		Mkt cap ! $302.4M

Open	High	Low	Value	Volume
$1.29	$1.29	$1.22	$3.277M	2.616M

Buyers (Bids)

No.	Vol.	Price($)
2	10721	$1.25

Sellers (Offers)

Price($)	Vol.	No.
$1.26	4455	1

View Market Depth

No.	Vol.	Price($)
2	10721	1.250
1	8032	1.245
2	8226	1.240
1	7226	1.235
2	23226	1.230

Price($)	Vol.	No.
1.255	4455	1
1.265	42226	2
1.270	30226	4
1.275	37905	2
1.280	7226	1

Last trade - 16.10pm 23/04/2025 (20 minute delay)

OCC (ASX) Chart

ORTHOCELL LIMITED - Announcements

Corporate SpotlightNot Yet Available

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories

Corporate Spotlight
Not Yet Available